Piribedil improves motor and non-motor Symptoms

被引：0
作者：
Ameri, Abdol A.
机构：
来源：
NERVENHEILKUNDE | 2011年 / 30卷 / 08期
关键词：
PARKINSONS-DISEASE; EARLY COMBINATION; BROMOCRIPTINE; DEMENTIA;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：631 / 632
页数：2
相关论文
共 10 条
  • [1] Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study
    Aarsland, D
    Andersen, K
    Larsen, JP
    Lolk, A
    Kragh-Sorensen, P
    [J]. ARCHIVES OF NEUROLOGY, 2003, 60 (03) : 387 - 392
  • [2] Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress
    Aarsland, D.
    Bronnick, K.
    Ehrt, U.
    De Deyn, P. P.
    Tekin, S.
    Emre, M.
    Cummings, J. L.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (01) : 36 - 42
  • [3] The Parkinson-control study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
    Castro-Caldas, A
    Delwaide, P
    Jost, W
    Merello, M
    Williams, A
    Lamberti, P
    Aguilar, M
    Del Signore, S
    Cesaro, P
    [J]. MOVEMENT DISORDERS, 2006, 21 (04) : 500 - 509
  • [4] Direct economic impact of Parkinson's disease: A research survey in the United Kingdom
    Findley, L
    Aujla, M
    Bain, PG
    Baker, M
    Beech, C
    Bowman, C
    Holmes, J
    Kingdom, WK
    MacMahon, DG
    Peto, V
    Playfer, JR
    [J]. MOVEMENT DISORDERS, 2003, 18 (10) : 1139 - 1145
  • [5] From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
    Millan, Mark J.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2010, 128 (02) : 229 - 273
  • [6] Millan MJ, 2001, J PHARMACOL EXP THER, V297, P876
  • [7] Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes
    Millan, MJ
    Maiofiss, L
    Cussac, D
    Audinot, V
    Boutin, JA
    Newman-Tancredi, A
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (02) : 791 - 804
  • [8] MILLAN MJ, 1995, J PHARMACOL EXP THER, V275, P885
  • [9] Peran P, 2004, EUR J NEUROL, V11, P286
  • [10] Norepinephrine: The redheaded stepchild of 'Parkinson's disease'
    Rommelfanger, K. S.
    Weinshenkey, D.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2007, 74 (02) : 177 - 190
1